Lawrence Kushi to California
This is a "connection" page, showing publications Lawrence Kushi has written about California.
Connection Strength
1.891
-
Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
Score: 0.153
-
Streamlining genetic testing for women with ovarian cancer in a Northern California health care system. Gynecol Oncol. 2020 10; 159(1):221-228.
Score: 0.114
-
Environmental Tobacco Smoke Exposure in Relation to Family Characteristics, Stressors and Chemical Co-Exposures in California Girls. Int J Environ Res Public Health. 2019 10 30; 16(21).
Score: 0.108
-
Neighborhood deprivation, race/ethnicity, and urinary metal concentrations among young girls in California. Environ Int. 2016 May; 91:29-39.
Score: 0.084
-
Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
Score: 0.082
-
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. JAMA Oncol. 2015 Sep; 1(6):737-45.
Score: 0.081
-
Brominated Flame Retardants and Other Persistent Organohalogenated Compounds in Relation to Timing of Puberty in a Longitudinal Study of Girls. Environ Health Perspect. 2015 Oct; 123(10):1046-52.
Score: 0.079
-
Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract. 2015 01; 11(1):e1-8.
Score: 0.076
-
Maternal hyperglycemia during pregnancy predicts adiposity of the offspring. Diabetes Care. 2014 Nov; 37(11):2996-3002.
Score: 0.076
-
Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
Score: 0.074
-
Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
Score: 0.066
-
The prevalence of obesity and obesity-related health conditions in a large, multiethnic cohort of young adults in California. Ann Epidemiol. 2012 Sep; 22(9):609-16.
Score: 0.065
-
Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
Score: 0.060
-
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
Score: 0.058
-
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
Score: 0.055
-
Body burdens of brominated flame retardants and other persistent organo-halogenated compounds and their descriptors in US girls. Environ Res. 2010 Apr; 110(3):251-7.
Score: 0.055
-
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
Score: 0.049
-
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Nov; 208(2):405-414.
Score: 0.038
-
Pubertal Timing Across Asian American, Native Hawaiian, and Pacific Islander Subgroups. JAMA Netw Open. 2024 May 01; 7(5):e2410253.
Score: 0.037
-
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
Score: 0.028
-
Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area. Int J Hyg Environ Health. 2019 08; 222(7):1038-1046.
Score: 0.026
-
Longitudinal study of age of menarche in association with childhood concentrations of persistent organic pollutants. Environ Res. 2019 09; 176:108551.
Score: 0.026
-
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
Score: 0.026
-
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
Score: 0.024
-
Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
Score: 0.023
-
Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
Score: 0.023
-
Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
Score: 0.023
-
Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
Score: 0.022
-
Associations of urinary phthalate and phenol biomarkers with menarche in a multiethnic cohort of young girls. Reprod Toxicol. 2017 01; 67:56-64.
Score: 0.022
-
Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
Score: 0.021
-
Thyroid Hormones and Timing of Pubertal Onset in a Longitudinal Cohort of Females, Northern California, 2006-11. Paediatr Perinat Epidemiol. 2016 May; 30(3):285-93.
Score: 0.021
-
Thyroid Antagonists (Perchlorate, Thiocyanate, and Nitrate) and Childhood Growth in a Longitudinal Study of U.S. Girls. Environ Health Perspect. 2016 Apr; 124(4):542-9.
Score: 0.020
-
Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
Score: 0.019
-
Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
Score: 0.018
-
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
Score: 0.017
-
Does neighborhood environment influence girls' pubertal onset? findings from a cohort study. BMC Pediatr. 2012 Mar 13; 12:27.
Score: 0.016
-
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
Score: 0.015
-
A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
Score: 0.014
-
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
Score: 0.014
-
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010 Sep 20; 28(27):4120-8.
Score: 0.014
-
Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect. 2010 Jul; 118(7):1039-46.
Score: 0.014
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.012
-
Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect. 2007 Jan; 115(1):116-21.
Score: 0.011
-
Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50.
Score: 0.011